Arhaus (NASDAQ:ARHS) reported quarterly earnings of $0.27 per share which beat the analyst consensus estimate of $0.14 by 92.86 percent. This is a 107.69 percent increase over earnings of $0.13 per share from the same period last year. The company reported quarterly sales of $320.00 million which beat the analyst consensus estimate of $203.00 million by 57.64 percent. This is a 57.38 percent increase over sales of $203.33 million the same period last year.
Leap Therapeutics Announces 1-For-10 Reverse Stock Split
Leap Therapeutics, Inc. (NASDAQ:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced that it will effect a 10-for-1 reverse stock split of its issued and
